Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 12461118)

1.

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW.

J Epidemiol Community Health. 2002 Dec;56(12):951-5. Review.

2.

Opportunities for minimization of confounding in observational research.

Quartey G, Feudjo-Tepie M, Wang J, Kim J.

Pharm Stat. 2011 Nov-Dec;10(6):539-47. doi: 10.1002/pst.528. Epub 2011 Nov 30.

PMID:
22127842
3.

Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.

Valenciano M, Kissling E, Ciancio BC, Moren A.

Vaccine. 2010 Oct 28;28(46):7381-8. doi: 10.1016/j.vaccine.2010.09.010. Epub 2010 Sep 17.

PMID:
20851086
4.

Associations of the correlates of protection and implication on the statistical power for demonstrating non-inferiority: application of a re-sampling method on a large phase III influenza vaccine clinical trial.

Bugarini R, Casula D, Groth N, Lattanzi M, Holmes S, Podda A.

Vaccine. 2010 Oct 28;28(46):7401-6. doi: 10.1016/j.vaccine.2010.08.102. Epub 2010 Sep 16.

PMID:
20850533
5.

Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research.

Groenwold RH, Nelson DB, Nichol KL, Hoes AW, Hak E.

Int J Epidemiol. 2010 Feb;39(1):107-17. doi: 10.1093/ije/dyp332. Epub 2009 Nov 30.

6.

Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy.

Nichol KL.

Vaccine. 2009 Oct 23;27(45):6305-11. doi: 10.1016/j.vaccine.2009.07.006.

PMID:
19840665
7.

Influenza vaccination and mortality benefits: new insights, new opportunities.

Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson L.

Vaccine. 2009 Oct 23;27(45):6300-4. doi: 10.1016/j.vaccine.2009.07.008.

PMID:
19840664
8.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
9.

Influenza vaccination and mortality: differentiating vaccine effects from bias.

Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R.

Am J Epidemiol. 2009 Sep 1;170(5):650-6. doi: 10.1093/aje/kwp173. Epub 2009 Jul 22.

10.

Pooling of confounders did not induce residual confounding in influenza vaccination studies.

Groenwold RH, Hak E, Hoes AW.

Ann Epidemiol. 2009 Jun;19(6):432-6. doi: 10.1016/j.annepidem.2009.02.001.

PMID:
19460673
11.

Pregnant women's knowledge of influenza and the use and safety of the influenza vaccine during pregnancy.

Yudin MH, Salaripour M, Sgro MD.

J Obstet Gynaecol Can. 2009 Feb;31(2):120-5.

PMID:
19327210
12.

Influenza vaccination concerns among older blacks: a randomized controlled trial.

Wray RJ, Buskirk TD, Jupka K, Lapka C, Jacobsen H, Pakpahan R, Gary E, Wortley P.

Am J Prev Med. 2009 May;36(5):429-434.e6. doi: 10.1016/j.amepre.2009.01.025. Epub 2009 Mar 6.

PMID:
19269130
13.

New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors.

Nelson JC, Jackson ML, Weiss NS, Jackson LA.

J Clin Epidemiol. 2009 Jul;62(7):687-94. doi: 10.1016/j.jclinepi.2008.06.014. Epub 2009 Jan 4.

PMID:
19124221
14.

Health benefits, risks, and cost-effectiveness of influenza vaccination in children.

Fleming DM, Elliot AJ.

Pediatr Infect Dis J. 2008 Nov;27(11 Suppl):S154-8. doi: 10.1097/INF.0b013e31818a5443.

PMID:
18955891
15.

Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.

Szilagyi PG, Fairbrother G, Griffin MR, Hornung RW, Donauer S, Morrow A, Altaye M, Zhu Y, Ambrose S, Edwards KM, Poehling KA, Lofthus G, Holloway M, Finelli L, Iwane M, Staat MA; New Vaccine Surveillance Network.

Arch Pediatr Adolesc Med. 2008 Oct;162(10):943-51. doi: 10.1001/archpedi.162.10.943.

PMID:
18838647
16.

Quantifying the potential role of unmeasured confounders: the example of influenza vaccination.

Groenwold RH, Hoes AW, Nichol KL, Hak E.

Int J Epidemiol. 2008 Dec;37(6):1422-9. doi: 10.1093/ije/dyn173. Epub 2008 Aug 25.

17.

New vaccine approaches for seasonal and pandemic influenza.

Palache B.

Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Epub 2008 Jul 30. Review.

PMID:
18674583
18.

Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.

Fukushima W, Hayashi Y, Mizuno Y, Suzuki K, Kase T, Ohfuji S, Fujieda M, Maeda A, Hirota Y.

Vaccine. 2008 Nov 25;26(50):6466-9. doi: 10.1016/j.vaccine.2008.06.038. Epub 2008 Jun 26.

PMID:
18582520
19.

Ecological fallacy and scepticism about influenza vaccine efficacy in Japan: the Maebashi study.

Hirota Y.

Vaccine. 2008 Nov 25;26(50):6473-6. doi: 10.1016/j.vaccine.2008.06.036. Epub 2008 Jun 23.

PMID:
18573298
20.

The effect of misclassification on evaluating the effectiveness of influenza vaccines.

Ozasa K.

Vaccine. 2008 Nov 25;26(50):6462-5. doi: 10.1016/j.vaccine.2008.06.039. Epub 2008 Jun 23. Review.

PMID:
18573297
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk